Open Journal of Psychiatry & Allied Sciences
Open Access
  • Year: 2016
  • Volume: 7
  • Issue: 1

Schizophrenia care: an overview considering family burden, medication adherence, and pharmacoeconomics

1Pharm D, Department of Pharmacy Practice, National College of Pharmacy, Kozhikode, Kerala, India

2Pharm D, Department of Pharmacy Practice, National College of Pharmacy, Kozhikode, Kerala, India

3Pharm D, Department of Pharmacy Practice, National College of Pharmacy, Kozhikode, Kerala, India

4MBBS, DPM, KMCT Medical College Hospital, Kozhikode, Kerala, India

*Corresponding author: Neethu Poulose, National College of Pharmacy, Manassery, Kozhikode, Kerala, India, PIN-673602. neethupoulosemadassery@gmail.com

Online published on 14 January, 2016.

Abstract

Schizophrenia is one of the leading causes of disability among all health problems. The discrimination and stigma are two unavoidable consequences of schizophrenia that individuals suffer most in developing countries. Management of schizophrenia has been brought out from silent asylums to community, providing them with more care and supports from family, healthcare professionals, and society. This article deals with the important aspects that one comes across while taking care of schizophrenic patients, such as family burden, medication adherence, and pharmacoeconomics. There are many interventions that should be implemented in solving problems associated with management of schizophrenia. Among them, role of psychotherapy and pharmacy-based intervention is unavoidable.

Keywords

Discrimination, Stigma, Cost Effectiveness, Cost of Illness, Interventions